NeoGenomics Inc. (NASDAQ:NEO) Drops -52.75% In 2022; Is It Affordable At $24.94? – Marketing Sentinel
Home  »  Business   »  NeoGenomics Inc. (NASDAQ:NEO) Drops -52.75% In 202...

NeoGenomics Inc. (NASDAQ:NEO) Drops -52.75% In 2022; Is It Affordable At $24.94?

In last trading session, NeoGenomics Inc. (NASDAQ:NEO) saw 0.63 million shares changing hands with its beta currently measuring 0.67. Company’s recent per share price level of $24.94 trading at -$0.05 or -0.20% at ring of the bell on the day assigns it a market valuation of $3.18B. That closing price of NEO’s stock is at a discount of -146.87% from its 52-week high price of $61.57 and is indicating a premium of 0.36% from its 52-week low price of $24.85. Taking a look at company’s average trading volume of 905.27K if we extend that period to 3-months.

For NeoGenomics Inc. (NEO), analysts’ consensus is at an average recommendation of a Buy while assigning it a mean rating of 1.70. Splitting up the data highlights that, out of 12 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 10 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.14 in the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


NeoGenomics Inc. (NASDAQ:NEO) trade information

Upright in the red during last session for losing -0.20%, in the last five days NEO remained trading in the red while hitting it’s week-highest on Tuesday, 01/11/22 when the stock touched $24.94 price level, adding 12.46% to its value on the day. NeoGenomics Inc.’s shares saw a change of -26.91% in year-to-date performance and have moved -11.09% in past 5-day. NeoGenomics Inc. (NASDAQ:NEO) showed a performance of -22.16% in past 30-days.

Wall Street analysts have assigned a consensus price target of $48.82 to the stock, which implies a rise of 48.91% to its current value. Analysts have been projecting $41.00 as a low price target for the stock while placing it at a high target of $60.00. It follows that stock’s current price would drop -140.58% in reaching the projected high whereas dropping to the targeted low would mean a loss of -64.39% for stock’s current value.

NeoGenomics Inc. (NEO) estimates and forecasts

Statistics highlight that NeoGenomics Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -42.94% of value to its shares in past 6 months, showing an annual growth rate of -280.00% while that of industry is 7.90. Apart from that, the company came lowering its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to decrease by -200.00% in the current quarter and calculating -275.00% decrease in the next quarter. This year revenue growth is estimated to rise 9.10% from the last financial year’s standing.

11 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $125.99 million for the same. And 9 analysts are in estimates of company making revenue of $128.79 million in the next quarter that will end on Mar 2022. Company posted $126 million and $115.53 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to shrink by -0.00% while estimating it to be 11.50% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 23.30% during past 5 years. In 2022, company’s earnings growth rate is likely to be around -51.70% while estimates for its earnings growth in next 5 years are of 12.30%.

NEO Dividends

NeoGenomics Inc. is more likely to be releasing its next quarterly report between February 22 and February 28 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

NeoGenomics Inc. (NASDAQ:NEO)’s Major holders

Insiders are in possession of 4.28% of company’s total shares while institution are holding 96.02 percent of that, with stock having share float percentage of 100.32%. Investors also watch the number of corporate investors in a company very closely, which is 96.02% institutions for NeoGenomics Inc. that are currently holding shares of the company. Blackrock Inc. is the top institutional holder at NEO for having 18.76 million shares of worth $904.94 million. And as of Sep 29, 2021, it was holding 15.24% of the company’s outstanding shares.

The second largest institutional holder is Vanguard Group, Inc. (The), which was holding about 12.67 million shares on Sep 29, 2021. The number of shares represents firm’s hold over 10.29% of outstanding shares, having a total worth of $611.22 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

On the other hand, iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Oct 30, 2021, the former fund manager was holding 8.28 million shares of worth $380.69 million or 6.72% of the total outstanding shares. The later fund manager was in possession of 3.31 million shares on Sep 29, 2021, making its stake of worth around $159.55 million in the company or a holder of 2.69% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts



Download Free eBook For



100% free. stop anytime no spam